跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,254 条关于
“Scholar Rock Holding Corp.”
全部
9,254
临床试验
6,641
药物
544
机构
633
资讯
1,436
去年
Scholar Rock's Apitegromab Shows Promise in SMA, Faces Financial and Development Hurdles
6个月前
Redmile Group Invests $49 Million in Scholar Rock as Apitegromab Nears Regulatory Resubmission
9个月前
Scholar Rock Faces Manufacturing Setback as FDA Issues Warning Letter to Catalent Partner Ahead of Apitegromab Launch
12个月前
FDA Issues Complete Response Letter for Scholar Rock's Apitegromab Due to Manufacturing Issues
去年
Scholar Rock's Stock Soars 440% Following Positive SAPPHIRE Trial Results
去年
Outlook Therapeutics Faces Setback in AMD Trial; Other R&D Updates
去年
Scholar Rock's Apitegromab Shows Clinically Meaningful Improvement in Phase 3 SMA Trial
2年前
Biotech Stock Roundup: Aldeyra Faces Setback, Annovis Bio Shows Positive Updates, and More
上个月
Scholar Rock Advances Apitegromab Toward September 30 PDUFA Date as First Muscle-Targeted Therapy for SMA
去年
Scholar Rock Submits Apitegromab BLA to FDA for Spinal Muscular Atrophy Treatment
第 1 页,共 144 页
上一页
下一页